| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total |
| 01/12/2022 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 420 | 84 | 0 | 0 | 0 | 504 |
| 09/12/2022 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 62 | 340 | 0 | 0 | 0 | 408 |
| 09/12/2022 | VACINA CONTRA SARS-COV2 - PEDIATRICA - MENOR DE 05 ANOS | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 10 | 10 | 0 | 0 | 0 | 100 |
| 12/01/2023 | VACINA CONTRA SARC-COV2 - 06 DOSES.. | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 211 |
| 19/01/2023 | VACINA CONTRA INSTITUTO BUTANTAN | Butantan/CoronaVac | 10 | 40 | 0 | 0 | 0 | 50 |
| 26/01/2023 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 150 |
| 26/01/2023 | VACINA CONTRA COVIF PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 150 |
| 06/02/2023 | VACINA CONTRA SARS- COV2 PEDIATRICA | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 4 | 10 | 0 | 0 | 0 | 324 |
| 23/02/2023 | VACINA CONTRA SARS-COV BIVALENTE BA1 - PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 180 |
| 01/03/2023 | VACINA CONTRA SARS-COV2 BIVALENTE - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 222 |
| 06/03/2023 | VACINA CONTRA SARS-COV2 BIVALENTE - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 198 |
| 16/03/2023 | VACINA CONTRA SARS-COV2 BIVALENTE - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 624 |
| 16/03/2023 | VACINA CONTRA COVID PFIZER | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 20 | 0 | 0 | 0 | 60 |
| 16/03/2023 | VACINA CONTRA SARS- COV2 PEDIATRICA | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 1 | 0 | 0 | 0 | 1 |
| 22/03/2023 | VACINA CONTRA SARS COV2 - BIVALENTE | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 36 |
| 22/03/2023 | VACINA CONTRA SARS COV BIVALENTE - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 144 |
| 22/03/2023 | VACINA CONTRA SARS COV - PEDIATRICA 10 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 60 | 0 | 0 | 0 | 0 | 107 |
| 22/03/2023 | VACINA CONTRA SARS COV - MENOR DE 5ANOS | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 100 | 80 | 0 | 0 | 0 | 210 |
| 22/03/2023 | VACINA CONTRA SARS COV - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 15 | 0 | 15 | 0 | 0 | 30 |
| 04/04/2023 | VACINA CONTRA SARS COV PED, MENOR DE 5 ANOS - 136 REMESSA | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 30 | 58 | 0 | 0 | 0 | 100 |
| 04/04/2023 | VACINA SARS COV PED - 10 DOSES, 136 REMESSA | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 20 | 20 | 0 | 0 | 0 | 140 |
| 04/04/2023 | VACINA CONTRA SARS COV BIVALENTE BA1- 06 DOSES, 136 REMESSA | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 204 |
| 11/04/2023 | VACINA CONTRA SARS-COV2 BIVALENTE | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 354 |
| 11/04/2023 | VACINA CONTRA SARS-COV2 BIVALENTE | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 330 |
| 11/04/2023 | VACINA CONTRA SARS-CV2 | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 354 |
| 28/04/2023 | VACINA CONTRA SARS-COV2 - PEDIATRICA | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 50 |
| 18/05/2023 | VACINA CONTRA SARS-COV2 BIVALENTE BA4/BA5-06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 54 |
| 18/05/2023 | VACINA CONTRA SARS-COV2 BIVALENTE | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 54 |
| 18/05/2023 | VACINA CONTRA SARS COV2 | Butantan/CoronaVac | 3 | 36 | 0 | 0 | 0 | 40 |
| 18/05/2023 | VACINA CONTRA SARS-COV2 CORONAVAC | Butantan/CoronaVac | 2 | 37 | 0 | 0 | 0 | 40 |
